AzTrials
AzTrials

Down SyndromeNCT05144373

Role of Early Motor Experience in Infants With Down Syndrome

A study testing Gross motor intervention, gross and fine motor intervention in people with Down Syndrome, run by Georgia State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Infants with Down syndrome show significant delays and weaknesses in motor, cognitive, and language development compared to typically developing infants. This project aims to examine the developmental cascade effects of specific gross and fine motor experience on motor, cognitive and language development in infants… Read more about this study

Who is it for?
Ages 7 to 36 months
Conditions the study is for
Down Syndrome
What is being tested?
Gross motor intervention, gross and fine motor intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
51 participants
Where
1 siteUnited States
Study dates
1 Jan 2022to 31 Aug 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 36 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • An appropriate age range of 7-36 months
  • A diagnosis of Down syndrome.

Who cannot join

  • The presence of seizure disorders
  • Non-correctable vision, hearing and heart problems
  • Any other severe medical conditions that may prevent the infant from participating in this study

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Biomechanics lab

    Atlanta, Georgia, 30302

Other trials in United States

About this study

Infants with Down syndrome show significant delays and weaknesses in motor, cognitive, and language development compared to typically developing infants. This project aims to examine the developmental cascade effects of specific gross and fine motor experience on motor, cognitive and language development in infants with Down syndrome. We propose that both gross and fine motor experience will facilitate cognitive and language development in infants with Down syndrome, and particularly, fine motor experience will help advance gesture and early words production.

Read the detailed description

Down syndrome (DS) is the most common genetic condition and causes significant development delays and weaknesses in the motor, cognitive, and language domains. It is important to study these co-occurring developmental challenges and develop effective intervention strategies for positive learning outcomes in multiple domains simultaneously. It was found that motor development is closely associated with cognitive and language development in typically developing infants and advances in motor development have developmental cascade effects on other domains. However, this interrelation has not been studied in infants with DS. Our prior work has shown that gross motor experience through body-weight-supported treadmill stepping leads to an earlier onset of walking and improves subsequent locomotor ability in infants with DS. However, we do not yet know the extent to which this motor experience advances cognitive and language development in infants with DS. Research also suggests that grasping, a major fine motor skill emerging in infancy, provides the needed scaffolding for subsequent gesture and speech production. However, research on grasping and its potential effects on other domains in infants with DS remains scarce. The objectives of this proposal are to understand: the role of (a) specific gross motor experience and (b) specific fine motor experience on the motor, cognitive and language development of infants with DS. Our central hypothesis is that motor (both gross and fine) experience will help advance cognitive and language development in infants with DS. We will recruit 45 infants with DS from the greater Atlanta area and beyond. There will be three groups: (a) gross motor (GM) group (n=15), entering the study at about 10 months of age; (b) gross motor plus fine motor (GM+FM) group (n=15), entering the study at about 10 months; and (c) control group (n=15), entering the study at about 20 months. Aim 1: Determine the effects of gross motor experience on cognitive and language development in infants with DS, comparing the GM and control groups. Only the GM group will receive a home-based, parent-guided practice of treadmill stepping from 10 months of age (T1) until onset of walking. We hypothesize that the GM group will show higher Bayley scores and better gesture and word production at termination of the GM intervention (T3) and five months thereafter (T4) than the control group. Aim 2: Determine the effects of fine motor experience on cognitive and language development in infants with DS who receive the GM intervention, particularly in gesture and word production, comparing the GM and GM+FM groups. Only the GM+FM group will receive fine motor experience in practice of grasping using "sticky mittens" from 10 months of age for about five months. We hypothesize that the GM+FM group will show further improvements in motor, cognitive and language domains, particularly in gesture and word production, than the GM group at termination of the FM intervention (T2) and again at T3 and T4. Our study will gain an in-depth understanding of the cascading effects of motor experience on cognitive and language development and lay the groundwork for future clinical trials in infants with DS.

Conditions
Down Syndrome
Being tested
Gross motor intervention, gross and fine motor intervention
Medical subject headings
Down Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Gross motor intervention, gross and fine motor interventionBehavioural

    For gross motor intervention, participants will receive a home-based, parent-administered body-weight supported treadmill intervention from about 10 months of age until walking onset.

    For gross and fine motor intervention, participants will receive the same treadmill intervention as illustrated above. In addition, participants will receive a fine motor intervention with practice of reaching and grasping using "sticky mittens" from about 10 months of age for five months.

Study groups in NCT05144373
Study groupRoleWhat they receive
Gross motor interventionExperimentalParticipants will receive a home-based, parent-administered body-weight supported treadmill intervention from about 10 months of age until walking onset.
Receives: Behavioral: Gross motor intervention, gross and fine motor intervention
Gross and fine motor interventionExperimentalBesides the body-weight supported treadmill intervention as illustrated above, participants will receive additional fine motor intervention using "sticky mittens" from about 10 months of age for five months.
Receives: Behavioral: Gross motor intervention, gross and fine motor intervention
ControlNo interventionParticipants will not receive specific intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bayley cognitive scores

    The Bayley Scale of Infant and Toddler Development cognitive composite scores

    Measured: 10 months for GM and GM+FM groups

  2. Bayley cognitive scores

    The Bayley Scale of Infant and Toddler Development cognitive composite scores

    Measured: 15 months for GM and GM+FM groups

  3. Bayley cognitive scores

    The Bayley Scale of Infant and Toddler Development cognitive composite scores

    Measured: 20 months for all three groups

  4. Bayley cognitive scores

    The Bayley Scale of Infant and Toddler Development cognitive composite scores

    Measured: 25 months for all three groups

  5. Bayley language scores

    The Bayley Scale of Infant and Toddler Development language composite scores

    Measured: 10 months for GM and GM+FM groups

  6. Bayley language scores

    The Bayley Scale of Infant and Toddler Development language composite scores

    Measured: 15 months for GM and GM+FM groups

  7. Bayley language scores

    The Bayley Scale of Infant and Toddler Development language composite scores

    Measured: 20 months for all three groups

  8. Bayley language scores

    The Bayley Scale of Infant and Toddler Development language composite scores

    Measured: 25 months for all three groups

  9. Gesture production

    It measures the type, frequency, and quality of gestures that the infant produces during infant-parent interaction

    Measured: 10 months for GM and GM+FM groups

  10. Gesture production

    It measures the type, frequency, and quality of gestures that the infant produces during infant-parent interaction

    Measured: 15 months for GM and GM+FM groups

  11. Gesture production

    It measures the type, frequency, and quality of gestures that the infant produces during infant-parent interaction

    Measured: 20 months for all three groups

  12. Gesture production

    It measures the type, frequency, and quality of gestures that the infant produces during infant-parent interaction

    Measured: 25 months for all three groups

Secondary outcomes (4)
  1. Bayley motor scores

    The Bayley Scale of Infant and Toddler Development motor composite scores

    Measured: 10 months for GM and GM+FM groups

  2. Bayley motor scores

    The Bayley Scale of Infant and Toddler Development motor composite scores

    Measured: 15 months for GM and GM+FM groups

  3. Bayley motor scores

    The Bayley Scale of Infant and Toddler Development motor composite scores

    Measured: 20 months for all three groups

  4. Bayley motor scores

    The Bayley Scale of Infant and Toddler Development motor composite scores

    Measured: 25 months for all three groups

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Dec 2021
  2. Study start1 Jan 2022
  3. Primary completion31 Aug 2025
  4. Study completion31 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Model description
We will recruit 45 infants with DS from the greater Atlanta area and beyond. There will be three groups: (a) gross motor (GM) group (n=15), entering the study at about 10 months of age; (b) gross motor plus fine motor (GM+FM) group (n=15), entering the study at about 10 months; and (c) control group (n=15), entering the study at about 20 months. The GM group will receive a home-based, parent-guided practice of treadmill stepping from 10 months of age until walking onset. The GM+FM group will receive both treadmill intervention from 10 months of age until walking onset as well as fine motor experience in practice of grasping using "sticky mittens" from 10 months of age for about five months. The control group will not receive an intervention.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
51 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05144373
Sponsor's protocol ID
H21604
Other IDs
1R21HD105879-01, 352307
Status last verified
Dec 2025
First submitted
5 Oct 2021
Last updated
11 Dec 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: We will upload the data to the National Institutes of Health INCLUDE data coordination center (DCC). We will share the de-identified data including demographics, diagnosis, and motor, cognitive, and language developmental profile. We will also share the video data including the captured motion data and the footage of parent-child interaction.

Questions about this trial

What is this clinical trial studying?

A study testing Gross motor intervention, gross and fine motor intervention in people with Down Syndrome, run by Georgia State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bayley cognitive scores (time frame: 10 months for GM and GM+FM groups). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in